Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) announced a monthly dividend on Wednesday, July 9th, Wall Street Journal reports. Investors of record on Friday, September 19th will be given a dividend of 0.1017 per share by the real estate investment trust on Tuesday, September 30th. This represents a $1.22 annualized dividend and a yield of 6.68%. The ex-dividend date is Friday, September 19th.
Healthpeak Properties has a payout ratio of 369.7% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Healthpeak Properties to earn $1.95 per share next year, which means the company should continue to be able to cover its $1.22 annual dividend with an expected future payout ratio of 62.6%.
Healthpeak Properties Price Performance
Shares of NYSE:DOC traded up $0.06 during trading on Wednesday, reaching $18.27. 5,034,364 shares of the company traded hands, compared to its average volume of 5,337,675. The company's 50 day moving average is $17.44 and its two-hundred day moving average is $19.00. The firm has a market capitalization of $12.69 billion, a PE ratio of 45.68, a PEG ratio of 2.05 and a beta of 1.03. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.01. Healthpeak Properties has a 52 week low of $16.64 and a 52 week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The business had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the prior year, the firm earned $0.45 EPS. The business's revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, sell-side analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current year.
Analysts Set New Price Targets
DOC has been the subject of a number of research reports. Robert W. Baird reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday. Wedbush dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wells Fargo & Company decreased their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Finally, Scotiabank decreased their target price on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research note on Monday, May 12th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, Healthpeak Properties has a consensus rating of "Moderate Buy" and an average target price of $23.27.
Read Our Latest Report on Healthpeak Properties
Insider Buying and Selling at Healthpeak Properties
In other Healthpeak Properties news, Director John T. Thomas bought 4,200 shares of the business's stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the purchase, the director owned 813,566 shares in the company, valued at approximately $14,514,017.44. This represents a 0.52% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Scott M. Brinker bought 2,750 shares of the stock in a transaction on Friday, May 9th. The shares were bought at an average price of $17.39 per share, for a total transaction of $47,822.50. Following the acquisition, the chief executive officer owned 204,613 shares in the company, valued at $3,558,220.07. The trade was a 1.36% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 29,764 shares of company stock valued at $521,909 in the last ninety days. Insiders own 0.23% of the company's stock.
Hedge Funds Weigh In On Healthpeak Properties
A number of hedge funds and other institutional investors have recently bought and sold shares of DOC. Integrated Wealth Concepts LLC raised its stake in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock worth $2,463,000 after acquiring an additional 63,930 shares during the last quarter. Finally, Woodline Partners LP boosted its holdings in Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock worth $1,195,000 after purchasing an additional 17,279 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.
About Healthpeak Properties
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.